Skip to ContentSkip to Navigation
Practical matters How to find us N. Singh

Publications

Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

PROGNOSTIC RELEVANCE OF THE MOLECULAR CLASSIFICATION IN HIGH-RISK ENDOMETRIAL CANCER: ANALYSIS OF THE PORTEC-3 TRIAL

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer

Read more